Funding for this research was provided by:
Saolta University Health Care Group (Clinical Research Career Development Award)
Healthy Ireland (Project Grant)
Received: 23 December 2019
Accepted: 11 March 2020
First Online: 16 March 2020
Ethics approval and consent to participate
: An ethical application was submitted to the Galway University Hospital Ethics board on the 05/07/2013. The ethics committee approved the study (C.A. 952) on the 19/07/2013. The site at which this study was conducted on was covered by the clinical indemnity scheme. We obtained written consent from all study participants.
: Not applicable.
: In the past (up to 2017), Francis Finucane received honoraria, travel grants and has served on advisory boards for Novo Nordisk, Eli Lilly, Pfizer Inc., Sanofi-Aventis, Astra Zeneca, Merck-Serono, Boehringer Ingelheim, Janssen and Novartis. Catherine Crowe, Clarissa Fang, Annette Murphy and Martin O’Donnell have no competing interest to declare.